175 related articles for article (PubMed ID: 17914572)
1. Establishment and characterization of a human cholangiocarcinoma cell line.
Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding.
Kim DG; Park SY; You KR; Lee GB; Kim H; Moon WS; Chun YH; Park SH
Genes Chromosomes Cancer; 2001 Jan; 30(1):48-56. PubMed ID: 11107175
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
Wilkens L; Hammer C; Glombitza S; Müller DE
Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis.
Rijken AM; Hu J; Perlman EJ; Morsberger LA; Long P; Kern SE; Hruban RH; Yeo CJ; Griffin CA
Genes Chromosomes Cancer; 1999 Nov; 26(3):185-91. PubMed ID: 10502315
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines.
Sriurairatana S; Tengchaisri T; Sirisinha S
Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):57-62. PubMed ID: 9031402
[TBL] [Abstract][Full Text] [Related]
8. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.
Luh F; Kuei A; Fann P; Chu P; Yen Y
Anticancer Res; 2009 Aug; 29(8):3239-43. PubMed ID: 19661341
[TBL] [Abstract][Full Text] [Related]
10. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
Kojima Y; Honda K; Hamada H; Kobayashi N
J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
[TBL] [Abstract][Full Text] [Related]
12. Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Ghosh M; Koike N; Tsunoda S; Hirano T; Kaul S; Kashiwagi H; Kawamoto T; Ohkohchi N; Saijo K; Ohno T; Miwa M; Todoroki T
Int J Oncol; 2005 Feb; 26(2):449-56. PubMed ID: 15645130
[TBL] [Abstract][Full Text] [Related]
13. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
15. [Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines].
Zhang DL; Li LJ; Xia GT; He XY; Gao BX; Bai XH; Huang GS; Liu SG; Yan LF; Fang FD; Hu CL; Wang LJ; Jiang HH; Feng AM; Zhang GM; An SG; Ren YQ; Guo JM; Hu SX; Fan JX; Niu YL; Song ZJ; Li Y; Fan SJ
Yi Chuan Xue Bao; 2001; 28(4):327-44. PubMed ID: 11329875
[TBL] [Abstract][Full Text] [Related]
16. Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine.
Enjoji M; Nakashima M; Honda M; Sakai H; Nawata H
Hepatology; 1997 Aug; 26(2):288-94. PubMed ID: 9252136
[TBL] [Abstract][Full Text] [Related]
17. Establishment and molecular cytogenetic characterization of non-small cell lung cancer cell line KU-T1 by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and chromosome microdissection.
Kume M; Taguchi T; Okada H; Anayama T; Tominaga A; Shuin T; Sasaguri S
Cancer Genet Cytogenet; 2007 Dec; 179(2):93-101. PubMed ID: 18036395
[TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
[TBL] [Abstract][Full Text] [Related]
19. p53 Mutations in human cholangiocarcinoma: a review.
Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
